# Prometa Pharmacotherapy for Methamphetamine Dependence

> **NCT00260481** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 120 (actual)

## Conditions studied

- Drug Abuse
- Drug Dependence

## Interventions

- **DRUG:** Prometa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00260481
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00260481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00260481, "Prometa Pharmacotherapy for Methamphetamine Dependence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00260481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*